Schedule 13D ownership disclosure
Silexion Therapeutics Corp
Security class unavailable · CUSIP: G1281K106
Event date: 2024-08-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-100344
- Form type
- SC 13D
- Filer
- Guangzhou Sino-Israel Bio-Industry Investment Fund LLP
- CIK
- CIK 2039018
- Filed
- Nov 20, 2024
- Reporting period
- Aug 15, 2024
- Description
- Schedule 13D beneficial ownership